Even though they didnt experience any negative side effects, they didnt think the capsules really tasted like anything and were a bit large
Ochiai M, Onishi K, Yamada T, et al
Despite the availability of ongoing advances in diabetes research and development, this chronic medical condition is often not diagnosed promptly and treated appropriately, thus leading to increased rates of death or long-term disability
10.1001/jama.287.23.3116 85
Among the 1,127 participants with prediabetes at baseline in the ATTAIN-1 trial, up to 91% of those taking orforglipron achieved normoglycemia (normal blood sugar levels) at 72 weeks, compared with only 42% of those taking placebo
What happens to your blood sugar if you stop GLP-1 for diabetes